BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
The centre offers a full spectrum of FDA-approved services, including physiotherapy, occupational therapy, speech and language therapy, and aqua therapy
The campaign builds on the three-year partnership unveiled earlier this season
Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
The company says the platform offers improved manufacturability and functional advantages
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
Subscribe To Our Newsletter & Stay Updated
